JDR Woodhead Publishing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Electronic Appendix
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Silwood, C.J.L.
Right arrow Articles by Grootveld, M.C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Silwood, C.J.L.
Right arrow Articles by Grootveld, M.C.

1H and 13C NMR Spectroscopic Analysis of Human Saliva

C.J.L. Silwood1, E. Lynch2, A.W.D. Claxson1, and M.C. Grootveld1,2,*

1 Medical Unit, St. Bartholomews and the Royal London School of Medicine and Dentistry, London E1 1BB, UK; and
2 School of Dentistry, The Queen's University of Belfast, Royal Victoria Hospital, Grosvenor Road, Belfast BT12 6BP, Northern Ireland;



View larger version (26K):

[in a new window]
 
Figure 1. Single-pulse 1D 1H NMR spectrum of a human salivary supernatant specimen. (a-c) Expanded 0.80-2.50, 2.55-4.20, and 6.85-8.50 ppm regions, respectively, of the 600.13-MHz single-pulse 1H NMR spectrum of a human salivary supernatant specimen (pH value 6.78). A typical spectrum is shown. Abbreviations: A, acetate-CH3; Ala I, alanine-CH3; Bu I, ß-hydroxybutyrate {gamma}-CH3 group protons; Bu II, III, and IV, ß-hydroxybutyrate ß, ß', and {alpha} protons, respectively (ABX coupling system); iso-But I and II, iso-butyrate-CH3 and -CH group protons, respectively; n-But I, II, and III, n-butyrate {gamma}, ß, and {alpha} protons, respectively; Chol, choline-N+(CH3)3; DMeN, dimethylamine-CH3; Eth I and II, ethanol-CH3 and -CH2 group protons, respectively; Form, formate-H; Gly, glycine-CH2; His I and II, histidine ABX ß protons; His III and IV, histidine imidazole ring protons; Lac I and II, lactate-CH3 and -CH protons, respectively; Leu I, II, III, and IV, leucine {delta}, {gamma}, ß, and {alpha} protons, respectively; MeGu, methylguanidine-CH3; MeN, methylamine-CH3; Meth, methanol-CH3; N-Ac, spectral region for acetamido methyl groups of N-acetyl sugars; Phe I and II, phenylalanine ABX ß protons; Phe III, phenylalanine ABX {alpha} proton; Phe IV, V, and VI, phenylalanine aromatic ring protons; Prop I and II, propionate-CH3 and -CH2 group protons, respectively; Pyr, pyruvate-CH3; Sar I and II, sarcosine-CH3 and -CH2 group protons, respectively; Suc, succinate-CH2; TMAO, trimethylamine oxide ON(CH3)3; TMeN, trimethylamine-CH3; Tyr I and II, tyrosine ABX ß protons; Tyr III, tyrosine ABX {alpha} proton; Tyr IV and V, tyrosine aromatic ring protons; and Val I and II, n-valerate {delta} and {gamma} protons, respectively. Assignments of 1H NMR resonances to methylguanidine, sarcosine, n-valerate, and N-acetylsugars are tentative in this instance.

 


View larger version (35K):

[in a new window]
 
Figure 2. Partial 1H-1H TOCSY NMR spectrum of a human salivary supernatant specimen. A typical spectrum is shown. KEY: 1, saturated fatty acid (terminal end spin system); 2, leucine; 3, saturated fatty acid (intermediate carbon spin system); 4, lysine; 5, unassigned; 6, {gamma}-aminobutyric acid; 7, ornithine; 8, unassigned; 9, isoleucine; 10, propionate; 11, valine; 12, glutamate; 13, glutamine; 14, proline; 15, unassigned; 16, propane-1,2-diol; 17, unassigned; 18, threonine; 19, unassigned; 20, phosphorylethanolamine; 21, tyrosine; 22, phenylalanine; 23, aspartic acid; 24, alanine; 25, ethanol; 26, lactate; and 27, 28, 29, and 30, unassigned.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
IADR Journals Advances in Dental Research ®
Journal of Dental Research ® Critical Reviews (1990-2004)
Copyright © 2002 Institutional Access Guidelines